Vansit Vajrabukka
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Vansit Vajrabukka’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C19308 · Cancelled
Licence status: Cancelled · since 1958 · University of Michigan Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,034
Medicare paid this office $1,034 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 72 · Under 65 0% · 85 and older 0% · Health risk score 0.80. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $9,125, Medicare allowed $1,540 and paid $1,034; for 16 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 16 | 72 | 0.80 | $9,125 | $1,034 |
| 2022 | 11 | 14 | 70 | 0.82 | $6,935 | $1,059 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$147,890
Pharmacies billed $147,890 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
234 generic and 83 brand-name prescriptions · $147,890 in drug cost · 14 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 18 | $70,339 | $3,908 |
| Atorvastatin | 22 | $282 | $13 |
Year by year
| 2024 | 317 | 184 | None | 26% | $147,890 |
| 2023 | 296 | 152 | None | None | $55,633 |
| 2022 | 357 | 161 | None | None | $24,914 |
| 2021 | 494 | 195 | None | None | $49,988 |
| 2020 | 356 | 172 | None | None | $69,893 |
| 2019 | 156 | 103 | None | 16% | $25,606 |
| 2018 | 117 | 82 | None | 22% | $18,438 |
| 2017 | 83 | 39 | None | None | $12,180 |
| 2016 | 52 | 32 | None | 25% | $2,146 |
| 2015 | 49 | 25 | 0% (0) | None | $2,452 |
| 2014 | 53 | 27 | None | 25% | $3,453 |
| 2013 | 13 | None | 0% (0) | None | $2,375 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Atorvastatin | 34 | $391 | $11 |
| Levothyroxine | 16 | $381 | $24 |
| Rosuvastatin | 13 | $371 | $29 |
| Metformin | 12 | $165 | $14 |
| Nitrofurantoin Mono-Macro | 11 | $110 | $10 |
2022: 4 drugs
| Atorvastatin | 26 | $373 | $14 |
| Losartan | 14 | $340 | $24 |
| Lisinopril | 20 | $225 | $11 |
| Amlodipine Besylate | 11 | $95 | $9 |
2021: 7 drugs
| Atorvastatin | 42 | $490 | $12 |
| Levothyroxine | 27 | $466 | $17 |
| Losartan | 21 | $365 | $17 |
| Escitalopram | 18 | $328 | $18 |
| Trazodone | 16 | $184 | $12 |
| Amlodipine Besylate | 12 | $105 | $9 |
| Lisinopril | 21 | $97 | $5 |
2020: 6 drugs
| Humalog Kwikpen U-100 | 11 | $6,099 | $554 |
| Levothyroxine | 36 | $755 | $21 |
| Atorvastatin | 15 | $304 | $20 |
| Losartan | 14 | $262 | $19 |
| Lisinopril | 17 | $156 | $9 |
| Hydrochlorothiazide | 14 | $79 | $6 |
2014: 1 drug
| Irbesartan | 12 | $841 | $70 |
Money from drug and device companies
$120 in 2025
| 2025 | 1 | 1 | None | $120 |
| 2024 | 1 | 2 | None | $143 |
| 2023 | 1 | 1 | None | $109 |
| 2022 | 2 | 3 | None | $170 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Yeztugo | $120 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2025-07-23 | Yeztugo | $120 |
See earlier years (2024, 2023, 2022)
2024: $143
| Gilead Sciences | None | $143 | 2 payments
|
2023: $109
| Gilead Sciences | None | $109 | 1 payment
|
2022: $170
| ViiV Healthcare | Apretude | $144 | 2 payments
|
| Gilead Sciences | None | $26 | 1 payment
|
Professional record
- NPI
- 1437489846
- Licence
- CA 19308California C19308: Cancelled
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2010-01-07
- NPI last updated
- 2025-09-18
- NPI record certified
- 2025-09-18
This is when the NPI record was last certified, not a medical board exam.